# EDGAR Filing Document

**Accession Number:** 0001512762
**File Stem:** 0001104659-25-118941
**Filing Date:** 2025-12
**Character Count:** 2587
**Document Hash:** 152185a74e5667f55884e2bf2d9f73ba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-118941.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001104659-25-118941

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Coherus Oncology, Inc.
- **CENTRAL INDEX KEY:** 0001512762
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 273615821
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** C/O DENNIS M. LANFEAR
- **STREET 2:** 333 TWIN DOLPHIN DR, SUITE 600
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065
- **BUSINESS PHONE:** (650) 649-3530

**MAIL ADDRESS:**
- **STREET 1:** C/O DENNIS M. LANFEAR
- **STREET 2:** 333 TWIN DOLPHIN DR, SUITE 600
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Coherus BioSciences, Inc.
- **DATE OF NAME CHANGE:** 20130114

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BioGenerics, Inc.
- **DATE OF NAME CHANGE:** 20110210

**Coherus Oncology, Inc.**

333 Twin Dolphin Drive, Suite 600

Redwood City, CA 94065

December 5, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

Re: Coherus Oncology, Inc. <br> Registration Statement on Form S-3 <br> (File No. 333-291520)

Ladies and Gentlemen:

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Coherus Oncology, Inc. (the "<u>Company</u>") hereby requests acceleration of the effective date of its Registration Statement on Form S-3 initially filed on November 13, 2025 (the "<u>Registration Statement</u>"). The Company respectfully requests that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on December 8, 2025, or as soon thereafter as practicable. Once the Registration Statement has been declared effective, please orally confirm that event with the Company's counsel, Latham & Watkins LLP, by calling Drew Capurro at (714) 755-8008.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| Coherus Oncology, Inc. | Coherus Oncology, Inc. |
| By: | /s/ Bryan McMichael |
| Name: | Bryan McMichael |
| Title: | Chief Financial Officer |

---

cc: Dennis M. Lanfear, Coherus Oncology, Inc. <br> Benjamin A. Potter, Latham & Watkins LLP <br> Drew Capurro, Latham & Watkins LLP